# Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression

> **NCT03062150** · NA · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 232 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Placebo
- **DRUG:** Fludrocortisone
- **DRUG:** D-Cycloserine

## Key facts

- **NCT ID:** NCT03062150
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-27
- **Primary completion:** 2019-02-11
- **Final completion:** 2019-02-11
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2020-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062150, "Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03062150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*